Acorda Therapeutics
ACOR
#10565
Rank
ยฃ0.61 M
Marketcap
ยฃ0.50
Share price
0.00%
Change (1 day)
-95.82%
Change (1 year)

Acorda Therapeutics (ACOR) - Cash on Hand

Cash on Hand as of March 2024 : ยฃ7.02 Million

According to Acorda Therapeutics 's latest financial reports the company has ยฃ7.02 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Acorda Therapeutics - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31ยฃ31.02 M-8.22%
2021-12-31ยฃ33.8 M-35.43%
2020-12-31ยฃ52.35 M-45.44%
2019-12-31ยฃ95.96 M-72.66%
2018-12-31ยฃ0.35 B54.49%
2017-12-31ยฃ0.22 B76.83%
2016-12-31ยฃ0.12 B-46.11%
2015-12-31ยฃ0.23 B20.66%
2014-12-31ยฃ0.19 B18.98%
2013-12-31ยฃ0.16 B14.79%
2012-12-31ยฃ0.14 B-24.01%
2011-12-31ยฃ0.19 B22.44%
2010-12-31ยฃ0.15 B-7.53%
2009-12-31ยฃ0.16 B0.16%
2008-12-31ยฃ0.16 B250.62%
2007-12-31ยฃ47.88 M74.47%
2006-12-31ยฃ27.44 M243.88%
2005-12-31ยฃ7.98 M-27.48%
2004-12-31ยฃ11 M-52.24%
2003-12-31ยฃ23.04 M
2003-06-30ยฃ36.74 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Repligen
RGEN
ยฃ0.56 B 7,896.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.10 B 15,682.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
ยฃ20.84 M 196.61%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Sarepta Therapeutics
SRPT
ยฃ0.63 B 8,987.92%๐Ÿ‡บ๐Ÿ‡ธ USA